Adma Biologics reported $83.21M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Adma Biologics USD 83.21M 4.02M Sep/2025
Alnylam Pharmaceuticals USD 881.04M 91.16M Sep/2025
Dynavax Technologies USD 73.6M 7.41M Sep/2025
Takeda JPY 1.02T 400.98B Dec/2025